Genpact Limited (G) fair value: what the stock is really worth
We calculate from audited financials what Genpact Limited is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily, free.
Compare price with fair valuebelow fair value = cheap, above = expensive
Check the quality50 and up solid, 75 and up strong
Watch it or check another stockalert when fair value or trend changes
Technology · US · Market cap $6.1B · ISIN BMG3922B1072
At a glance
GLGenpact LimitedG · US
Price$34.41
Fair Value$60.20
Upside+75.0%
Quality70/100
A solid business, trading 43% below our fair value of $60.20.
As of Sep 6, 2026, the fair value of Genpact Limited is $60.20 per share against a price of $34.41, so the fair value sits 75% above the price. A model estimate from reported figures, not an analyst target.
!Mixed Growth (revenue 5y +6.5 %/yr)
✓Solidly profitable · 11.0% net margin
✓Low debt · generates free cash flow
·2.03% dividend yield
✓Ranks above peers (11/15)
✓Wide moat 68/100
Evidence: HighRange $43.81 to $76.59
Fair value as of: Sep 6, 2026
From 26 valuation models · updated 5 days ago
Share price +1.3% over the past month.
This is the short version. In the app for Genpact Limited:
Watch Genpact Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for free
69 individual criteria per stock, every one traceable See the method →
What matters now
The rarer combination: high quality (70/100) AND below fair value. That earns a closer look rather than a quick verdict.
The price is below even our cautious bear case ($43.81). The market is more pessimistic than our downside scenario.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 6, 2026.
How to read this chart
60‑month range $27.50 – $54.13 · fair‑value band $43.81 – $76.59 · the $34.41 price screens below the $60.20 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 6, 2026.
Genpact Limited (G) currently trades at $34.41, while our model-based Fair Value estimate is $60.20, implying the stock looks roughly 42.8% undervalued today. The Quality Score stands at 70/100 (solid quality), in the Technology sector. Bull case: the DCF Models group reads highest at a median of $71.24 per share, and 19 of the 26 models we run sit above the $34.41 price. Bear case: the Asset-Based group reads lowest at $10.08, and 7 of the 26 models stay below the price. Evidence for this calculation is high.
Over the trailing twelve months, Genpact Limited generated revenue of $5.2B at a net margin of 11.0%. Revenue grew 6.7% year over year. It earns a return on equity of 23.1%. Net debt stands at $911M. Fundamentals as of Sep 6, 2026
Scenario range: $43.81 (bear) to $76.59 (bull), the price of $34.41 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target. The share trades about 29% below its 52-week high and 20% above its 52-week low, currently below its 200-day average. For context, the median of 10 Technology peers we cover trades at 79% fair-value upside, at 75%, G screens richer than that median.
Fair Value models
Based on fiscal year 2025 figures (about 8 months old). Earnings retained since then ($1.78 per share) are deliberately not added.
Each model values the company its own way; the fair value above is the evidence-weighted blend. Evidence (0 to 100) shows how complete a model's inputs are. How we calculate →
ModelBear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence
Free, no payment details. Unsubscribe anytime in one click.
Key figures & financial health
P/E ratio10.6
P/S ratio1.15P/E × margin
EPS (TTM)$3.26price ÷ EPS = P/E 10.6
Dividend yield2.0%payout 21.4%
Net margin10.9%FY2025
Return on equity23.1%TTM
More key figures
Profitability
Return on assets (EBIT)12.3%avg 5y
Operating margin15.4%TTM
Growth
Revenue (TTM)$5.2BTTM
Revenue growth (YoY)+6.7%3y avg +5.1%
EPS growth (YoY)+17.8%
Balance sheet & cash flow
Free cash flow$735MFY2025
Net debt$911MFY2025 · ≈ 1.2 yrs of FCF
Figures from reported company fundamentals · as of Sep 6, 2026. TTM = trailing twelve months.
Quality Score breakdown
Overall quality70/100
Of which business quality 68
· Market factors (momentum, volatility) 40
Profitability62
Margins and returns on capital today
Quality Growth36
Are margins and returns improving?
Cashflow71
Earnings quality: real cash, not paper profit
Fin. Strength74
Balance sheet, leverage, solvency risk
Investment66
Disciplined investing over empire-building
Low Volatility69
Calm price path (market factor)
Momentum31
Price trend over the last 3–12 months (market factor)
52W Momentum24
Distance to the 52-week high (market factor)
Net Issuance100
Buybacks instead of dilution
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
Genpact Limited provides business process outsourcing and information technology services in India, the rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing.
Full company description
Genpact Limited provides business process outsourcing and information technology services in India, the rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers customer onboarding, customer service, collections, retail and commercial loan operations, payment operations, mortgage origination and servicing, compliance, wealth management, capital market operations support, financial crime and risk management, proprietary insurance policy suite, underwriting support, new business processing, policy administration, customer, claims management, catastrophe and exposure/risk modeling, actuarial services, end-to-end third-party administration for property and casualty claims, and technology services. The Consumer and Healthcare segment provides demand generation, sensing and planning, supply chain planning and management, pricing and trade promotion management, deduction recovery management, order management, digital commerce, customer experience, lifecycle management, regulatory operations, chemistry manufacturing control compliance, regulatory information management, claims processing and adjudication, claims recovery and payment integrity, revenue cycle management, health equity analytics, and care services. The High Tech and Manufacturing segment offers solutions for trust and safety, advertising sales support, customer and user experience, customer care support, supply chain management, direct and indirect procurement, logistics, field, aftermarket support, and engineering services. It offers digital operations, data-tech-AI, advisory, agent technology; enterprise functional services, such as finance and accounting, human resources, sales and commercial operations, marketing, and global business solutions. The company has strategic alliance with Google Cloud. The company was founded in 1997 and is based in Hamilton, Bermuda.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Genpact Limited reported revenue of $5.1B in FY2025 versus $4.0B in FY2021, a compound +6.0%/yr. Reported net income was $552M in FY2025, compounding +10.6%/yr from FY2021.
Growth Quality 74/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
$5.1B
Latest YoY
+6.6%
Avg. revenue growth/yr (3Y) ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+5.1%
Avg. revenue growth/yr (5Y) ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+6.5%
Avg. revenue growth/yr (23Y) ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+13.2%
Value creation/yr (5Y) ⓘEarnings growth per share (CAGR 5 years, adjusted) plus dividend yield: value created per share and year.
+15.2%
Earnings growth per share plus dividend yield: the value created per share and year.
Earnings growth per share+13.2%
Dividend yield2.0%
Trend ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.5Y 14.7% vs 10Y 11.1%, picking up
Operating margin (EBIT) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.11.8% (2020) → 15.0% (2025) · rising
Worst earnings drop50% (2008) · in USD
Revenue+6.0%/yr
FY21$4.0B
FY22$4.4B
FY23$4.5B
FY24$4.8B
FY25$5.1B
Net income+10.6%/yr
FY21$369M
FY22$353M
FY23$631M
FY24$514M
FY25$552M
Character of growth · EPS growth decomposed (2014-2025)+12.7 % p.a.
Revenue per share+10.0 %
of which total revenue +7.8 % · buybacks/dilution +2.1 %
EBIT margin+1.1 %
Tax rate+0.7 %
Residual (interest, one-offs)+0.6 %
Annual growth per factor. These are factors, not summands: multiplied they give the EPS growth rate, added they do not quite. Start and end points are 3-year averages (details on hover).
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation
Quality Score70 · Top 25%
Fair Value upside+61% · Top 25%
Profitability
Return on equity (TTM)23% · Top 25%
Return on assets9% · Top 25%
Net margin (TTM)11% · Top 25%
Operating margin (TTM)15% · Top 25%
Growth and dividend
Revenue growth7% · Above median
Dividend yield (TTM)2.0% · Above median
Balance sheet
Debt / equity0.47× · Highest 25%
Valuation Multiples vs Information Technology Services median · lower = cheaper
P/E (TTM)10.6× · Cheapest 25%
P/B2.08× · Pricier than median
P/S (TTM)1.03× · Pricier than median
P/FCF7.2× · Pricier than median
EV/EBITDA6.5× · Cheaper than median
PEG1.16× · Cheaper than median
What the price implies (reverse DCF)
The inverse question: what free-cash-flow growth must Genpact Limited deliver for ten years so that today's price is fair in our DCF model? Same formula, same discount rate as the fair value.
Implied FCF growth, 10 years-5.3 % per year
Achieved revenue growth, 5 years+6.5 % p.a.
Sector median revenue growth+4.6 %
FCF yield on price12.09 %
Discount rate (WACC) in the models8.8 %
The price demands less growth than the company recently delivered: even a weaker business would justify the price. Ranking of the largest stocks →
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
This stockSector peers
VALUE100· sector 35
FUTURE34· sector 31
PAST92· sector 34
HEALTH77· sector 97
DIVIDEND41· sector 35
Insider activity: 46/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
None of the checked exposures detected
Similar stocks
10 more Information Technology Services stocks, each showing price versus our Fair Value estimate (as of Sep 6, 2026).
As of Sep 6, 2026, our model estimates a fair value of $60.20 versus a price of $34.41, about +75% upside (undervalued).
What is the fair value of G?
Our model-based fair value for Genpact Limited is $60.20 (as of Sep 6, 2026), built from audited fundamentals. The current price: $34.41.
What is the quality score of G?
Genpact Limited has a Quality Score of 70/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Genpact Limited (G)?
Our model-based price target is the fair value of $60.20 (as of Sep 6, 2026) from 26 valuation models. Cautious scenario $43.81, optimistic scenario $76.59. It is a calculation from audited fundamentals, not an analyst target.
What is the Genpact Limited stock forecast for 2026?
Our models put fair value at $60.20, about +75% upside versus a price of $34.41 (undervalued). Cautious scenario $43.81, optimistic scenario $76.59. The calculation is refreshed regularly with new filings.
What is the revenue of Genpact Limited (G)?
Genpact Limited reported trailing-twelve-month revenue of about $5.2B (latest available figure, as of Sep 6, 2026).
What is the net profit margin of G?
The net profit margin of Genpact Limited is about 11.0%, meaning it keeps roughly 11.0% of revenue as net income. Based on the latest reported figures.
Does Genpact Limited pay a dividend?
Genpact Limited currently shows a dividend yield of about 2.03% relative to its recent price (as of Sep 6, 2026).
What growth is priced into Genpact Limited (G)?
For today's price to be fair in a discounted-cash-flow model, Genpact Limited would have to grow free cash flow by -5.3 % per year for ten years (discount rate 8.8 %, then 2 % perpetual growth). Over the last 5 years revenue grew +6.5 % per year. As of Sep 6, 2026.
What discount rate (WACC) does the fair value of G use?
Our models discount Genpact Limited at 8.8 %: a base by market capitalisation (mid), damped by beta 0.62, country premium for USA. The same rate applies in all 26 models.
What is the intrinsic value of Genpact Limited (G)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Genpact Limited it is $60.20 per share (as of Sep 6, 2026), against a price of $34.41. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Genpact Limited stock overvalued or undervalued in 2026?
As of Sep 6, 2026, G trades below its calculated fair value: price $34.41, fair value $60.20, a gap of about +75% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of G?
No. The price is what the market pays today ($34.41); the fair value is what the company's own numbers justify ($60.20). For Genpact Limited the two are $25.79 per share apart. That gap is exactly why we show both numbers side by side.
How much is Genpact Limited worth?
The market values Genpact Limited at about $6.1B (market capitalisation, as of Sep 6, 2026). Per share that is $34.41; our models calculate a fair value of $60.20 per share.
What do the bullish and bearish scenarios say about G?
Our models span a range for Genpact Limited: cautious scenario $43.81, base $60.20, optimistic $76.59 per share (as of Sep 6, 2026, price $34.41). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of G?
Genpact Limited trades at a price-to-earnings ratio of 10.6 (as of Sep 6, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $60.20 is built from several models across several years. Other multiples: PEG 1.2, P/B 2.1, P/S 1.0, EV/EBITDA 6.5.
What is the PEG ratio of G?
The PEG ratio of Genpact Limited is 1.16 (P/E divided by earnings growth, as of Sep 6, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Genpact Limited (G)?
Balance-sheet figures for Genpact Limited (as of Sep 6, 2026): return on equity 23.1%, debt of 0.47 per unit of equity. They feed the Quality Score of 70/100, which measures business quality independently of the share price.
How far is G from its 52-week high?
Genpact Limited trades at $34.41, about 29% below its 52-week high of $48.40 and 20% above the low of $28.78 (as of Sep 6, 2026). Distance from the high says nothing about value: that is what the fair value of $60.20 is for.
Which stocks are comparable to Genpact Limited?
From the same area (Technology) we also value International Business Machines Corporation, Accenture plc, Tata Consultancy Services Limited, Infosys Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Genpact Limited stock attractive at the current price?
The data as of Sep 6, 2026: price $34.41, calculated fair value $60.20 (+75%), Quality Score 70/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of G calculated?
We run Genpact Limited through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $60.20, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 32.6 % above its aggregate fair value. Genpact Limited currently trades 75 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on <a href="/is-it-worth-investing-now/">is it worth investing now</a>.
Free · no account needed
Watch Genpact Limited in the live analysis
One click puts Genpact Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Genpact Limited
G · US